Torrent Pharmaceuticals Stock Price - ₹4,558.90 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Torrent Pharmaceuticals Stock Price - ₹4,558.90 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q4 FY15	Q1 FY16	Q2 FY16	Q3 FY16	Q4 FY16	Q1 FY17	Q2 FY17	Q3 FY17	Q4 FY17	Q1 FY18	Q2 FY18	Q3 FY18	Q4 FY18	Q1 FY19	Q2 FY19	Q3 FY19	Q4 FY19	Q1 FY20	Q2 FY20	Q3 FY20	Q4 FY20	Q1 FY21	Q2 FY21	Q3 FY21	Q4 FY21	Q1 FY22	Q2 FY22	Q3 FY22	Q4 FY22	Q1 FY23	Q2 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Sales	1,154	1,947	1,693	1,542	1,503	1,551	1,429	1,443	1,434	1,374	1,417	1,463	1,708	1,872	1,894	2,051	1,856	2,022	2,005	1,966	1,946	2,056	2,017	1,995	1,937	2,134	2,137	2,106	2,131	2,347	2,291	2,491	2,491	2,591	2,660	2,732	2,745	2,859	2,889	2,809	2,959	3,178	3,302	3,303	4,197	4,921
Expenses	992	1,035	976	1,118	1,016	1,114	1,099	1,127	1,139	1,077	1,088	1,104	1,344	1,395	1,421	1,490	1,383	1,481	1,464	1,426	1,398	1,395	1,382	1,388	1,355	1,457	1,477	1,570	1,570	1,635	1,612	1,767	1,764	1,800	1,835	1,863	1,862	1,955	1,950	1,895	1,995	2,146	2,219	2,215	2,841	3,257
EBITDA	162	912	717	424	487	437	330	316	295	297	329	359	364	477	473	561	473	541	541	540	548	661	635	607	582	677	660	536	561	712	679	724	727	791	825	869	883	904	939	914	964	1,032	1,083	1,088	1,356	1,664
Depreciation	60	57	59	59	63	68	69	73	97	80	84	94	151	150	152	156	160	160	163	163	168	161	165	167	165	165	168	167	162	155	163	193	196	191	201	213	203	197	198	199	201	201	204	206	508	593
EBIT	102	855	658	365	424	369	261	243	198	217	245	265	213	327	321	405	313	381	378	377	380	500	470	440	417	512	492	369	399	557	516	531	531	600	624	656	680	707	741	715	763	831	879	882	848	1,071
Interest	47	55	48	43	38	49	51	48	58	56	51	80	121	122	126	133	123	122	116	111	102	102	92	91	73	68	71	62	57	55	69	102	107	103	91	80	80	75	64	57	56	56	48	45	236	305
Profit Before Tax	55	800	610	322	386	320	210	195	140	161	194	185	92	205	195	272	190	259	262	266	278	398	378	349	344	444	421	307	342	502	447	429	424	497	533	576	600	632	677	658	707	775	831	837	612	766
Net Profit	130	650	509	290	284	292	207	229	206	188	204	58	228	163	179	246	-152	216	244	251	314	321	310	297	324	330	316	249	-118	354	312	292	287	378	386	443	449	457	453	503	498	548	591	635	364	566
EPS	7.7	38.4	30.01	17.19	16.82	17.28	12.25	13.47	12.17	11.08	12.07	3.37	13.55	9.66	10.57	14.5	-8.95	12.74	14.48	14.77	18.56	18.98	18.32	17.52	19.16	19.53	18.63	14.75	-6.97	20.9	9.22	8.63	8.48	11.18	11.39	13.1	13.27	13.51	13.37	14.88	14.71	16.19	17.54	18.77	11.51	14.87

Cashflow

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Operating Cash Flow	810.2	2,742.12	1,008.84	894.15	1,798.08	1,392.91	2,005.35	1,802.99	2,368.13	3,266.08	2,585.11	3,022.71
Investing Cash Flow	-2,112.55	-869.49	-798.22	-4,677.07	-245.61	229.19	-443.82	-196.1	-2,335.36	-159.83	-548.78	-12,629.6
Financing Cash Flow	1,212.25	-1,435.15	-192.91	3,417.39	-1,314.45	-1,549.04	-1,650.79	-1,781.05	77.36	-2,779.64	-2,297.99	10,150.6
Net Cash Flow	-90.1	437.48	17.71	-365.53	238.02	73.06	-89.26	-174.16	110.13	326.61	-261.66	543.71

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	2,490.99	3,494.56	4,350.62	4,622.71	4,724.35	4,823.22	5,837.17	5,952.95	6,198.07	6,856.15	7,590.69	17,584.83
Total Liabilities	5,412.81	5,563.32	5,351.47	9,620.51	9,396.57	9,186.52	8,237.48	7,146.89	8,813.78	8,204.43	7,399.05	26,727.13
Total Assets	7,903.8	9,057.88	9,702.09	14,243.2	14,120.9	14,009.7	14,074.7	13,099.8	15,011.8	15,060.6	14,989.7	44,312

Shareholding

₹1.7L CrMarket Cap

Promoter & promoter group (68.31%)

DIIs (9.83%)

FIIs (15.44%)

Public & others (6.42%)